Skip to main content
. 2016 Sep 14;24(5):381–389. doi: 10.3727/096504016X14685034103392

Figure 3.

Figure 3

ARMC8 silencing inhibits the growth of osteosarcoma in vivo. MG-63 cells (1 × 106 cells/0.1 ml) transfected with ARMC8-shRNA or scr-shRNA were injected subcutaneously into the flank of nude mice. (A) The tumor volumes were calculated in each group every 7 days from day 0 to day 35. (B) The tumor weights were measured at day 35. Data represent mean ± SD. *p < 0.05.